Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Amneal Pharmaceuticals Inc., 3 years.
Amneal Pharmaceuticals Inc.
Director
Hims & Hers Health Inc.
Director · Chief Policy Officer
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Hims & Hers Health Inc. June 11, 202699.9%
-
Hims & Hers Health Inc. June 12, 202599.9%
-
Amneal Pharmaceuticals Inc. May 8, 202599.4%
-
Amneal Pharmaceuticals Inc. May 2, 202499.4%
-
Amneal Pharmaceuticals Inc. May 9, 202399.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Hims & Hers Health Inc. | Open-market sale | −16,773 | $27.85 | $467,128 |
| Aug 14, 2026 | Hims & Hers Health Inc. | Option exercise | +32,920 | — | — |
| Aug 14, 2026 | Hims & Hers Health Inc. | Shares withheld for tax | −16,147 | $28.15 | $454,538 |
| Jun 15, 2026 | Hims & Hers Health Inc. | Option exercise | +32,919 | — | — |
| Jun 15, 2026 | Hims & Hers Health Inc. | Shares withheld for tax | −15,396 | $30.17 | $464,497 |
| Jun 11, 2026 | Hims & Hers Health Inc. | Option exercise | +3,656 | — | — |
| May 11, 2026 | Amneal Pharmaceuticals Inc. | Open-market sale | −34,819 | $12.94 | $450,558 |
| May 7, 2026 | Amneal Pharmaceuticals Inc. | Option exercise | +34,819 | — | — |
| Mar 13, 2026 | Hims & Hers Health Inc. | Option exercise | +32,919 | — | — |
| Mar 13, 2026 | Hims & Hers Health Inc. | Shares withheld for tax | −11,312 | $24.77 | $280,198 |
| Dec 17, 2025 | Hims & Hers Health Inc. | Open-market sale | −7,054 | $36.71 | $258,952 |
| Dec 15, 2025 | Hims & Hers Health Inc. | Option exercise | +7,054 | — | — |
| Jun 12, 2025 | Hims & Hers Health Inc. | Option exercise | +6,175 | — | — |
| May 5, 2025 | Amneal Pharmaceuticals Inc. | Option exercise | +40,258 | — | — |
| Nov 22, 2024 | Amneal Pharmaceuticals Inc. | Open-market sale | −33,229 | $8.34 | $277,130 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.